News came out at 7am the company had positive preclinical data on their drugs reach and activity in major pancreatic cancer metastatic sites. Stock went from 4.50 to 28 in 5 min. Came back down to 12 and I saw it start to ramp up and got in. Should've sold near 16, but thought it could go more given the volume coming in the range from 4-28. Glad I got out when I did, before the hard drop to 5.50. Cut losses quickly!